Revolutionizing Pharma: The Strategic Guide to AI Deployment
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Ann Arbor Stage III Hodgkin Lymphoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB12001
Abemaciclib
1
Terminated
1
DB05812
Abiraterone
1
Terminated
1
DB08916
Afatinib
1
Terminated
1
DB00062
Albumin human
1
Terminated
1
DB09495
Avobenzone
1
Terminated
1
DB00112
Bevacizumab
1
Terminated
1
DB01128
Bicalutamide
1
Terminated
1
DB00188
Bortezomib
1
Terminated
1
DB16741
Bortezomib D-mannitol
1
Terminated
1
DB06772
Cabazitaxel
1
Terminated
1
DB08875
Cabozantinib
1
Terminated
1
DB01101
Capecitabine
1
Terminated
1
DB00958
Carboplatin
1
Terminated
1
DB00482
Celecoxib
1
Terminated
1
DB05239
Cobimetinib
1
Terminated
1
DB12483
Copanlisib
1
Terminated
1
DB08912
Dabrafenib
1
Terminated
1
DB11963
Dacomitinib
1
Terminated
1
DB12941
Darolutamide
1
Terminated
1
DB01254
Dasatinib
1
Terminated
1
DB00694
Daunorubicin
1
Terminated
1
DB00997
Doxorubicin
1
Terminated
1
DB11714
Durvalumab
1
Terminated
1
DB13874
Enasidenib
1
Terminated
1
DB11986
Entrectinib
1
Terminated
1
DB08899
Enzalutamide
1
Terminated
1
DB00530
Erlotinib
1
Terminated
1
DB01590
Everolimus
1
Terminated
1
DB00544
Fluorouracil
1
Terminated
1
DB09054
Idelalisib
1
Terminated
1
DB00619
Imatinib
1
Terminated
1
DB06186
Ipilimumab
1
Terminated
1
DB09078
Lenvatinib
1
Terminated
1
DB00650
Leucovorin
1
Terminated
1
DB12130
Lorlatinib
1
Terminated
1
DB00678
Losartan
1
Terminated
1
DB11828
Neratinib
1
Terminated
1
DB09035
Nivolumab
1
Terminated
1
DB09496
Octinoxate
1
Terminated
1
DB09074
Olaparib
1
Terminated
1
DB00526
Oxaliplatin
1
Terminated
1
DB01229
Paclitaxel
1
Terminated
1
DB09073
Palbociclib
1
Terminated
1
DB06603
Panobinostat
1
Terminated
1
DB09037
Pembrolizumab
1
Terminated
1
DB06366
Pertuzumab
1
Terminated
1
DB08901
Ponatinib
1
Terminated
1
DB08896
Regorafenib
1
Terminated
1
DB08877
Ruxolitinib
1
Terminated
1
DB00877
Sirolimus
1
Terminated
1
DB00398
Sorafenib
1
Terminated
1
DB01268
Sunitinib
1
Terminated
1
DB08911
Trametinib
1
Terminated
1
DB05773
Trastuzumab emtansine
1
Terminated
1
DB00755
Tretinoin
1
Terminated
1
DB08881
Vemurafenib
1
Terminated
1
DB11581
Venetoclax
1
Terminated
1
DB08828
Vismodegib
1
Terminated
1
DB02546
Vorinostat
1
Terminated
1
DB08870
Brentuximab vedotin
1 / 2
Active Not Recruiting
1
DB00851
Dacarbazine
1 / 2
Active Not Recruiting
1
DB00997
Doxorubicin
1 / 2
Active Not Recruiting
1
DB03366
Imidazole
1 / 2
Active Not Recruiting
1
DB00570
Vinblastine
1 / 2
Active Not Recruiting
1
DB08870
Brentuximab vedotin
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB12887
Tazemetostat
2
Active Not Recruiting
1
DB08870
Brentuximab vedotin
3
Active Not Recruiting
1
DB00851
Dacarbazine
3
Active Not Recruiting
1
DB00997
Doxorubicin
3
Active Not Recruiting
1
DB00099
Filgrastim
3
Active Not Recruiting
1
DB03366
Imidazole
3
Active Not Recruiting
1
DB00570
Vinblastine
3
Active Not Recruiting
1